Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Kathleen M Wyvill"'
Autor:
Nazzarena Labo, Wendell Miley, Vickie Marshall, William Gillette, Dominic Esposito, Matthew Bess, Alexandra Turano, Thomas Uldrick, Mark N Polizzotto, Kathleen M Wyvill, Rachel Bagni, Robert Yarchoan, Denise Whitby
Publikováno v:
PLoS Pathogens, Vol 10, Iss 3, p e1004046 (2014)
The Kaposi sarcoma associated herpesvirus (KSHV) genome encodes more than 85 open reading frames (ORFs). Serological evaluation of KSHV infection now generally relies on reactivity to just one latent and/or one lytic protein (commonly ORF73 and K8.1)
Externí odkaz:
https://doaj.org/article/a2baf30b576441df8c29053bc13572ff
Autor:
Jana M Kainerstorfer, Mark N Polizzotto, Thomas S Uldrick, Rafa Rahman, Moinuddin Hassan, Laleh Najafizadeh, Yasaman Ardeshirpour, Kathleen M Wyvill, Karen Aleman, Paul D Smith, Robert Yarchoan, Amir H Gandjbakhche
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e83887 (2013)
Diffuse multi-spectral imaging has been evaluated as a potential non-invasive marker of tumor response. Multi-spectral images of Kaposi sarcoma skin lesions were taken over the course of treatment, and blood volume and oxygenation concentration maps
Externí odkaz:
https://doaj.org/article/9934fb632bb14836aacfdf0c6adad4f9
Autor:
Diana V. Pastrana, Alberto Peretti, Nicole L. Welch, Cinzia Borgogna, Carlotta Olivero, Raffaele Badolato, Lucia D. Notarangelo, Marisa Gariglio, Peter C. FitzGerald, Carl E. McIntosh, Jesse Reeves, Gabriel J. Starrett, Valery Bliskovsky, Daniel Velez, Isaac Brownell, Robert Yarchoan, Kathleen M. Wyvill, Thomas S. Uldrick, Frank Maldarelli, Andrea Lisco, Irini Sereti, Christopher M. Gonzalez, Elliot J. Androphy, Alison A. McBride, Koenraad Van Doorslaer, Francisco Garcia, Israel Dvoretzky, Joceline S. Liu, Justin Han, Philip M. Murphy, David H. McDermott, Christopher B. Buck
Publikováno v:
mSphere, Vol 3, Iss 6 (2018)
ABSTRACT Several immunodeficiencies are associated with high susceptibility to persistent and progressive human papillomavirus (HPV) infection leading to a wide range of cutaneous and mucosal lesions. However, the HPV types most commonly associated w
Externí odkaz:
https://doaj.org/article/23f9f824fd734e23af44698af7c43b3a
Autor:
Robert Yarchoan, Denise Whitby, Giovanna Tosato, William Douglas Figg, Seth M. Steinberg, Kathryn Lurain, Anaida Widell, Priscila Goncalves, Kathleen M. Wyvill, Mark N. Polizzotto, Thomas S. Uldrick, Ramya Ramaswami
Kaplan-Meier curve of duration of response among 9 responders on the study, measured from the date of response (as compared with baseline) till progression or censorship when patient follow-up ended. Median time to progression was not reached. Hatch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64b205133a8589475809d53b14dc086b
https://doi.org/10.1158/1078-0432.22471605
https://doi.org/10.1158/1078-0432.22471605
Autor:
Robert Yarchoan, Thomas S. Uldrick, Denise Whitby, Seth M. Steinberg, Priscila Goncalves, Jomy George, Anaida Widell, Kathleen M. Wyvill, Kathryn Lurain, Mark N. Polizzotto, Ramya Ramaswami
Supplementary Table from Safety, Activity, and Long-term Outcomes of Pomalidomide in the Treatment of Kaposi Sarcoma among Individuals with or without HIV Infection
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ab1784d3a5b61ae2ca2ab98e8898763
https://doi.org/10.1158/1078-0432.22486467
https://doi.org/10.1158/1078-0432.22486467
Autor:
Robert Yarchoan, Thomas S. Uldrick, Denise Whitby, Seth M. Steinberg, Priscila Goncalves, Jomy George, Anaida Widell, Kathleen M. Wyvill, Kathryn Lurain, Mark N. Polizzotto, Ramya Ramaswami
Supplementary Figure from Safety, Activity, and Long-term Outcomes of Pomalidomide in the Treatment of Kaposi Sarcoma among Individuals with or without HIV Infection
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b01b7cf64a651016c09fe653b33722c
https://doi.org/10.1158/1078-0432.22486470.v1
https://doi.org/10.1158/1078-0432.22486470.v1
Autor:
Robert Yarchoan, Denise Whitby, Giovanna Tosato, William Douglas Figg, Seth M. Steinberg, Kathryn Lurain, Anaida Widell, Priscila Goncalves, Kathleen M. Wyvill, Mark N. Polizzotto, Thomas S. Uldrick, Ramya Ramaswami
Purpose:VEGF-A is important in the pathogenesis of Kaposi sarcoma, and bevacizumab has a response rate of 31%. We explored the combination of bevacizumab with liposomal doxorubicin in patients with Kaposi sarcoma.Patients and Methods:Patients with Ka
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb4f444920e13540146449021ebc6d4a
https://doi.org/10.1158/1078-0432.c.6527946
https://doi.org/10.1158/1078-0432.c.6527946
Autor:
Robert Yarchoan, Denise Whitby, Giovanna Tosato, William Douglas Figg, Seth M. Steinberg, Kathryn Lurain, Anaida Widell, Priscila Goncalves, Kathleen M. Wyvill, Mark N. Polizzotto, Thomas S. Uldrick, Ramya Ramaswami
Supplementary Table 2: Analysis of changes in serum VEGF-A and inflammatory cytokines between responders and non-responders after 6 cycles of treatment with bevacizumab and liposomal doxorubicin. *P values are for the difference between responders an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96e15ef349123e7621638b25438e5189
https://doi.org/10.1158/1078-0432.22471599.v1
https://doi.org/10.1158/1078-0432.22471599.v1
Autor:
Robert Yarchoan, Denise Whitby, Giovanna Tosato, William Douglas Figg, Seth M. Steinberg, Kathryn Lurain, Anaida Widell, Priscila Goncalves, Kathleen M. Wyvill, Mark N. Polizzotto, Thomas S. Uldrick, Ramya Ramaswami
Diagram to represent the treatment course and responses among patients treated within the study. *Patient had progressive disease of cutaneous KS but continued with treatment due to improvement in symptomatic pulmonary KS.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::735a00c7efea22529893f81c12f3d609
https://doi.org/10.1158/1078-0432.22471608
https://doi.org/10.1158/1078-0432.22471608
Autor:
Robert Yarchoan, Denise Whitby, Giovanna Tosato, William Douglas Figg, Seth M. Steinberg, Kathryn Lurain, Anaida Widell, Priscila Goncalves, Kathleen M. Wyvill, Mark N. Polizzotto, Thomas S. Uldrick, Ramya Ramaswami
CD4 Count at baseline and after 6 cycles of combination therapy. . * For all patients, those in cohort 1 and 2, P values test the equality of the matched pair of CD4 counts from baseline to 6 cycles using Wilcoxon signed rank tests. All other P value
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5852dee7bf67c936a3eafc8e140c74e9
https://doi.org/10.1158/1078-0432.22471602
https://doi.org/10.1158/1078-0432.22471602